Loading candles…
Fermenta Biotech Ltd. operates as a vertically integrated company within the nutritional, pharmaceutical, and biotechnology industries. It is recognized as one of the few global manufacturers of Vitamin D3 and has a leadership position in enzymatic technologies. The company produces a range of products including ingredients for human and animal nutrition, niche active pharmaceutical ingredients (APIs), and environmental biotechnology solutions. Its business segments focus primarily on the nutritional and pharmaceutical sectors. Fermenta Biotech Ltd. serves more than 60 countries worldwide. No additional information about incorporation details, founders, key management, subsidiaries, or stock exchange listings is provided.
| Index Review | NSE indices rebalancing | 31 Mar 2026 |
| Expiry | Monthly F&O expiry | 30 Jan 2026 |
| Expiry | Monthly F&O expiry | 27 Feb 2026 |
| Holiday | Republic Day — market closed | 26 Jan 2026 |
Besseggen InfoTech LLP is a SEBI-registered stock broker (Reg. No. INZ000213450), member of NSE (90155 (Cash & F&O)) and BSE (6722 (Cash & F&O)). Investment in securities market are subject to market risks; read all related documents carefully before investing.